Enliven Therapeutics Inc.
ELVN
$59.32-0.55%
End of day · as of Sep 6, 2026, 4:45 AM ET
Mkt cap
$2.11B
EV/Sales
N/A
P/E ratio
N/A
Revenue (FY2025)
N/A
EPS (H1 2026)
$-0.87
Gross Margin (FY2025)
N/A
Profit Margin (FY2025)
N/A
Beta
0.40
Div yield
N/A
Sector
Healthcare
Enliven Therapeutics Inc. (ELVN) is a biotechnology company listed on US.
Use this ELVN research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full ELVN income, balance, and cash tables.
Enliven Therapeutics Inc. (ELVN) is a biotechnology company in the Healthcare sector.
Latest cached Enliven Therapeutics Inc. (ELVN) net income for FY2025 was -$103.7M. Statements: https://lician.com/financials/elvn
Enliven Therapeutics Inc. (ELVN) market capitalization is $2.11B on the latest cached snapshot.
Enliven Therapeutics Inc. (ELVN) cached previous close $59.65; day range $58.97 – $59.89; volume 1,111,934. Session quote: https://lician.com/quote/elvn
Enliven Therapeutics Inc. (ELVN) latest cached earnings event is "ELVN earnings" on Aug 12, 2026. Earnings calendar: https://lician.com/earnings
The latest cached ELVN filing is 8-K · Oct 14, 2026. Filings: https://lician.com/sec/elvn